CA125 is elevated in noncancerous conditions such as endometriosis, fibroids, liver disease, and menstruation, leading to fluctuations, false positives, patient anxiety, and unnecessary interventions (19, 35–38). This evidence concerns the gene MUC16 and leiomyoma.